Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer

被引：0
|
作者：
Chiang, Anne C.
Asghari, Hossein
Ashley, Kerryan
Gettinger, Scott N.
Goldberg, Sarah B.
Herbst, Roy S.
Wilson, Frederick Hugh
Newton, Benjamin Robert
Cohenuram, Michael Keith
Sabbath, Kert D.
Talsania, Ashita D.
Russo, Armand Vincent
Schultz, Eric
Skrzypczak, Stan
Kingsford, Carl
Schalper, Kurt A.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Ocean Genom, Pittsburgh, PA USA
[3] Yale Univ, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, New Haven, CT USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Smilow Canc Hosp Yale New Haven, Yale Sch Medicinel, Yale Canc Ctr, New Haven, CT USA
[7] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8597
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?
    Califano, R.
    Gomes, F.
    Ackermann, C. J.
    Rafee, S.
    Tsakonas, G.
    Ekman, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 1 - 11
  • [42] Combination therapy using low-dose anlotinib and immune checkpoint inhibitors for extensive-stage small cell lung cancer
    Li, Han
    Yuan, Shumin
    Wu, Han
    Wang, Yajie
    Ma, Yichen
    Tang, Xiance
    Fu, Xiaomin
    Zhao, Lingdi
    Xu, Benling
    Li, Tiepeng
    Qin, Peng
    You, Hongqin
    Han, Lu
    Wang, Zibing
    CANCER INNOVATION, 2024, 3 (06):
  • [43] Discussion to: Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
    Feldman, Hope
    Bott, Matthew
    Mehran, Reza J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (04): : 1454 - 1455
  • [44] Exploratory Analysis for Predictors of Benefit of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
    Owonikoko, T.
    Dahlberg, S.
    Poirier, J.
    Sica, G.
    Rudin, C.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1766 - S1767
  • [45] Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients
    Li, Jianan
    Zhang, Wentao
    Zhao, Yi
    Li, Jixian
    Nie, Yuanliu
    Feng, Alei
    Li, Qiang
    Zhou, Fengge
    Zeng, Renya
    Yang, Zhe
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [46] Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
    Canale, Matteo
    Urbini, Milena
    Petracci, Elisabetta
    Angeli, Davide
    Tedaldi, Gianluca
    Priano, Ilaria
    Cravero, Paola
    Flospergher, Michele
    Andrikou, Kalliopi
    Bennati, Chiara
    Tassinari, Davide
    Dubini, Alessandra
    Rossi, Giulio
    Panzacchi, Riccardo
    Valli, Mirca
    Bronte, Giuseppe
    Crino, Lucio
    Delmonte, Angelo
    Ulivi, Paola
    LUNG CANCER-TARGETS AND THERAPY, 2025, 16 : 11 - 23
  • [47] Role of prophylactic cranial irradiation in limited and extensive-stage small cell lung cancer
    Lim, Y. J.
    Song, C.
    Kim, H. J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S991 - S992
  • [48] The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
    Verma, Saurav
    Young, Sympascho
    Louie, Alexander V.
    Palma, David
    Breadner, Daniel
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [49] What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
    Nesbit, Eric G.
    Leal, Ticiana A.
    Kruser, Tim J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S153 - S162
  • [50] RAMUCIRUMAB PLUS ATEZOLIZUMAB IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Herzog, Brett
    Waqar, Saiama
    Devarakonda, Siddhartha
    Ward, Jeffrey
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A480 - A480
12345